睡眠障碍与阿尔茨海默病连续谱中脑淀粉样蛋白及tau负荷、皮层萎缩和认知功能障碍的关联
这项回顾性队列研究纳入138例18F-florbetaben PET阳性的阿尔茨海默病连续谱受试者,分析总睡眠时间与淀粉样蛋白、tau负荷、皮层萎缩及认知功能的关系。结果发现总睡眠时间较长与tau累积(尤其在内侧颞叶等区域)及记忆减退相关,并预测tau累积加快和疾病进展。
要点
- 阿尔茨海默病痴呆组总睡眠时间(7.4±1.6小时)长于临床前组(6.5±1.4小时;p=0.026)和前驱期组(6.6±1.4小时;p=0.001)。
- 总睡眠时间较长与tau累积相关,尤其在内侧颞叶、基底前脑、岛叶、扣带回、枕叶、下颞叶皮层及楔前叶。
- 总睡眠时间较长预测Braak V-VI区tau累积加快(β=0.016,p=0.007)及疾病进展至轻度认知障碍或痴呆(风险比=1.554,p=0.024)。
核心结论
- 总睡眠时间延长与睡眠相关皮层及皮层下区域tau累积和记忆功能障碍相关,并预测tau累积加快和疾病进展。
- 作者认为评估总睡眠时间作为阿尔茨海默病连续谱疾病严重程度和预后标志物具有临床重要性。
研究设计与样本
- 回顾性队列研究,纳入138例18F-florbetaben PET阳性的阿尔茨海默病连续谱受试者(临床前15例、前驱期62例、痴呆期61例;平均年龄73.4±8.0岁;女性58.7%)。
- 所有受试者完成匹兹堡睡眠质量指数、脑MRI、18F-florbetaben PET、18F-flortaucipir PET和详细神经心理测试,部分受试者完成随访评估。
- 分析总睡眠时间与基线及纵向18F-florbetaben标准化摄取值比、18F-flortaucipir标准化摄取值比、皮层厚度和认知域综合评分的关联。
主要发现
- 阿尔茨海默病痴呆组总睡眠时间为7.4±1.6小时,长于临床前组(6.5±1.4小时;p=0.026)和前驱期组(6.6±1.4小时;p=0.001),其他睡眠参数组间无差异。
- 总睡眠时间较长与淀粉样蛋白累积无关联,而与tau累积相关,尤其在内侧颞叶、基底前脑、岛叶、扣带回、枕叶、下颞叶皮层及楔前叶。
- 总睡眠时间较长预测Braak V-VI区tau累积加快(β=0.016,p=0.007)及疾病进展至轻度认知障碍或痴呆(风险比=1.554,p=0.024)。
- 总睡眠时间较长与记忆减退相关(β=-0.19,p=0.008)。
临床怎么用
- 作者认为评估总睡眠时间可作为阿尔茨海默病连续谱疾病严重程度和预后的标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients with Alzheimer disease (AD) frequently suffer from various sleep disturbances. However, how sleep disturbance is associated with AD and its progression remains poorly investigated. We investigated the association of total sleep time with brain amyloid and tau burden, cortical atrophy, cognitive dysfunction, and their longitudinal changes in the AD spectrum. METHODS: In this retrospective cohort study, we enrolled participants on the AD spectrum who were positive on 18F-florbetaben (FBB) PET. All participants underwent the Pittsburgh Sleep Quality Index, brain MRI, FBB PET, 18F-flortaucipir (FTP) PET, and detailed neuropsychological testing. In addition, a subset of participants completed follow-up assessments. We analyzed the association of total sleep time with the baseline and longitudinal FBB-standardized uptake value ratio (SUVR), FTP-SUVR, cortical thickness, and cognitive domain composite scores. RESULTS: We examined 138 participants on the AD spectrum (15 with preclinical AD, 62 with prodromal AD, and 61 with AD dementia; mean age 73.4 ± 8.0 years; female 58.7%). Total sleep time was longer in the AD dementia group (7.4 ± 1.6 hours) compared with the preclinical (6.5 ± 1.4 hours; p = 0.026) and prodromal groups (6.6 ± 1.4 hours; p = 0.001), whereas other sleep parameters did not differ between groups. Longer total sleep time was not associated with amyloid accumulation but rather with tau accumulation, especially in the amygdala, hippocampus, basal forebrain, insular, cingulate, occipital, inferior temporal cortices, and precuneus. Longer total sleep time predicted faster tau accumulation in Braak regions V-VI (β = 0.016, p = 0.007) and disease progression to mild cognitive impairment or dementia (hazard ratio = 1.554, p = 0.024). Longer total sleep time was also associated with memory deficit (β = -0.19, p = 0.008). DISCUSSION: Prolonged total sleep time was associated with tau accumulation in sleep-related cortical and subcortical areas as well as memory dysfunction. It also predicted faster disease progression with tau accumulation. Our study highlights the clinical importance of assessing total sleep time as a marker for disease severity and prognosis in the AD spectrum.
引用
- Yoon SH, Kim HK, Lee JH, et al. Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical Atrophy, and Cognitive Dysfunction Across the AD Continuum. Neurology. 2023. PMID: 37813585. doi:10.1212/WNL.0000000000207917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。